Home>Topics>Stocks>Celgene Corporation

Celgene Corporation CELG

  1. All
  2. Commentary
  3. Headlines
    1. From Barron’s, March 31, 2014 (Part 2)

      Commentary

      Sat, 29 Mar 2014

      performance relative to sectors such as IT that require lesser capex. Some highflyers sank last week, e.g. biotechs [ ALXN, CELG , GILD, REGN ] and other momentum favorites [ GMCR, FB, TWTR, P, YELP, NFLX, BIDU ]; fears of higher rates and weaker

    2. Credit Market Outlook: Bonds Priced for the Benign

      Headlines

      Wed, 26 Mar 2014

      Issuer Rating Maturity Coupon Price Yield Spread to Treas Celgene CELG A 2023 4.00% $101.75 3.78% 118 Juniper Networks JNPR ..... yield, and spread are provided by Advantage Data. Celgene CELG (rating: A, narrow moat) We believe significant spread tightening

    3. Wintergreen Fund - Annual Report

      Commentary

      Thu, 6 Mar 2014

      from the finanacial crisis (E TRADE Financial Corporation (NASDAQ:ETFC)), a biotechnology company ( Celgene Corporation (NASDAQ: CELG )), and two poster children of a potential new internet bubble (Netflix, Inc. (NASDAQ:NFLX) and

    4. Did the Government Shutdown Help the Economy?

      Headlines

      Tue, 10 Dec 2013

      discretionary stocks, Netflix (NFLX) is the leader, and within the health care sector, biotechnology companies, such as Celgene ( CELG ), have increased the most. Ranking sectors and stocks this way, it’s easy to identify and follow the leaders. It’s like Newton

    5. From Barron’s, October 14, 2013 (Part 2)

      Commentary

      Sat, 12 Oct 2013

      page/9_0210-investorsentimentreadings.html Bullish stories: 6 stocks with rising earnings estimates [ ALL, COF, CELG , SJM, OXY, SNA ; pg 21]; semiconductor equipment maker Kulicke & Soffa [ KLIC ; forward P/E 3 after backing out $6

    6. Share Repurchase: Potential Signal of Undervaluation and Outperformance

      Headlines

      Mon, 16 Sep 2013

      Celgene's CELG prized drug Revlimid was approved for multiple myeloma in June, and third-quarter results gave us our first look at sales for

    7. Do These Comeback Kids Have Long-Term Prospects?

      Headlines

      Thu, 8 Aug 2013

      Legg Mason Capital Management Value Trust. Like its sibling, the performance of some aggressive stock picks, such as Celgene CELG and Groupon GRPN, have helped that fund so far this year. Like Miller, Peters has an appetite for lower-quality fare and

    8. Raising Our FV for Celgene on Positive MM-020 Results and Boosted International Revlimid Forecast

      Commentary

      Thu, 11 Jul 2013

      We're raising our fair value estimate for Celgene CELG to $120 per share from $108 per share, largely owing to positive data from the firm's MM-020 study. We have also slightly

    9. Our Outlook for the Credit Markets

      Headlines

      Wed, 26 Jun 2013

      Diversifying products may emerge from Celgene 's CELG (rating: A, narrow moat) pipeline soon ..... 3.25% $97.25 3.58% 140 Celgene CELG A 2022 3.25% $98.63 3.42% 135 ..... represents an attractive value. Celgene CELG (rating: A) Although Celgene received

    10. Boosting Biotech Valuations on Lower Cost of Equity Assumptions

      Commentary

      Mon, 13 May 2013

      recommending buy or sell) for firms that have particularly high reliance on one product. For example, we continue to assign Celgene CELG a high uncertainty rating, to account for the fact that more than two thirds of the firm's sales stem from cancer drug Revlimid

    « Prev12345Next »
    Content Partners